[1]
Basim Najm, M., Jalal, S.D. and Getta, H.A. 2022. The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience: JAK2 V617F, CALR and MPL mutations as molecular diagnostic markers. Cellular and Molecular Biology. 68, 8 (Aug. 2022). DOI:https://doi.org/10.14715/cmb/2022.68.8.34 .